CP-547,632

A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called vascular endothelial growth factor (VEGF) receptor inhibitors and angiogenesis inhibitors.

Sustancia en estudio para el tratamiento de cáncer. Es un tipo de inhibidor del receptor del factor de crecimiento vascular endotelial (FCEV) y de inhibidor de la angiogénesis.